We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$102M
1-Year Est. Return
59.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.76%
1 Year Est. Return
+59.84%
3 Year Est. Return
+135.67%
5 Year Est. Return
+165.06%
10 Year Est. Return
–
AUM
$124M
AUM Growth
-$13.6M
(-9.9%)
Cap. Flow
-$14.3M
Cap. Flow
% of AUM
-11.47%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
143
New
1
Increased
2
Reduced
135
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$166K |
| 2 |
Nextpower Inc
NXT
|
+$101K |
| 3 |
AXS Green Alpha ETF
NXTE
|
+$1.27K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$559K |
| 2 |
Lam Research
LRCX
|
+$555K |
| 3 |
IBM
IBM
|
+$429K |
| 4 |
CRISPR Therapeutics
CRSP
|
+$423K |
| 5 |
Qualcomm
QCOM
|
+$422K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.01% |
| 2 | Real Estate | 16.13% |
| 3 | Healthcare | 6.95% |
| 4 | Consumer Staples | 6.8% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Quantum-Si Incorporated
QSI
$179M
| $136K | 0.11% |
129,259
-5,357
| -4% | -$8.59K |
|
127
Prime Medicine
PRME
$565M
| $135K | 0.11% |
26,245
-7,493
| -22% | -$45.4K |
|
128
Butterfly Network
BFLY
$1.73B
| $135K | 0.11% |
160,200
-6,844
| -4% | -$6.39K |
|
129
Personalis
PSNL
$1.61B
| $127K | 0.1% |
108,591
-10,362
| -9% | -$14.2K |
|
130
Caribou Biosciences
CRBU
$164M
| $127K | 0.1% |
77,371
-6,150
| -7% | -$19.7K |
|
131
Gogoro
GGR
$68.9M
| $111K | 0.09% |
3,609
-199
| -5% | -$6.14K |
|
|
VERV
132
DELISTED
Verve Therapeutics
VERV
| $94.8K | 0.08% |
19,433
-5,507
| -22% | -$34.6K |
|
133
Energy Vault
NRGV
$554M
| $92.5K | 0.07% |
97,446
-4,461
| -4% | -$5.54K |
|
134
Ginkgo Bioworks
DNA
$517M
| $74.4K | 0.06% |
5,567
-1,874
| -25% | -$55.9K |
|
135
AbCellera Biologics
ABCL
$1.97B
| $73.1K | 0.06% |
24,709
-3,638
| -13% | -$13.8K |
|
|
CVAC
136
DELISTED
CureVac
CVAC
| $65.8K | 0.05% |
19,340
-2,778
| -13% | -$9.09K |
|
137
Pacific Biosciences
PACB
$447M
| $46.7K | 0.04% |
34,096
-15,851
| -32% | -$32K |
|
|
MAXN
138
DELISTED
Maxeon Solar Technologies
MAXN
| $38.2K | 0.03% |
447
-14
| -3% | -$2.96K |
|
139
Arcturus Therapeutics
ARCT
$172M
| – | – |
-8,414
| Closed | -$284K |
|
|
EXAS
140
DELISTED
Exact Sciences
EXAS
| – | – |
-4,469
| Closed | -$309K |
|
141
Intellia Therapeutics
NTLA
$1.59B
| – | – |
-7,964
| Closed | -$219K |
|
142
10x Genomics
TXG
$5.55B
| – | – |
-5,713
| Closed | -$214K |
|
|
NVTA
143
DELISTED
Invitae Corporation
NVTA
| – | – |
-450,148
| Closed | -$4.95K |
|
Similar funds
CG
SSA
BAM
GIA
OCM
BCM
PCP
JF
Green Alpha Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Green Alpha Advisors held 143 positions worth $124M, down 9.9% from $138M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Green Alpha Advisors withdrew a net $14.3M in Q2 2024, closing 5 positions and reducing 135 holdings. Its most notable exit was Exact Sciences, an estimated $309K position sold in full.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Green Alpha Advisors opened a new position in Guardant Health worth $205K.
- Green Alpha Advisors's largest Q2 2024 buy was Guardant Health: 7,108 shares worth $205K.
- Green Alpha Advisors added most to Nextpower Inc in Q2 2024, an estimated $101K increase.
- Green Alpha Advisors's biggest Q2 2024 reduction was TSMC, cutting an estimated $559K.
- Green Alpha Advisors fully exited Exact Sciences in Q2 2024, selling an estimated $309K.
- Green Alpha Advisors's ten largest holdings make up 24% of its $124M portfolio in Q2 2024.
- Green Alpha Advisors opened 1 new position and closed 5 in Q2 2024.
- Green Alpha Advisors's portfolio value fell 9.9% quarter-over-quarter to $124M.
Based on Green Alpha Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.